Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00525304 · ClinicalTrials.gov registry record · NA

A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition

A NA study of Schizophrenia, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT00525304: Completed NA study of Schizophrenia, sponsored by University of Maryland, Baltimore.

NCT00525304 is a NA study of Schizophrenia that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 100 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00525304, a NA study of Schizophrenia, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

Conditions Studied

Interventions

  • BEHAVIORAL Self-management program for chronic illness

Study Locations (1)

Maryland

  • Fayette Street Clinics - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2007-09
Est. Completion 2015-05
Phase NA
University of Maryland, Baltimore

560 total trials

What the finished NCT00525304 record still lists

NCT00525304 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Self-management program for chronic illness is the first listed.

NCT00525304 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00525304 about?

NCT00525304 is a clinical study titled "A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition". This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

What is the current status of trial NCT00525304?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2007-09. Estimated completion is 2015-05.

What conditions does trial NCT00525304 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT00525304?

The interventions under investigation include: Self-management program for chronic illness (BEHAVIORAL).

Who is sponsoring clinical trial NCT00525304?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00525304 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00525304's enrollment target sits among peer trials

100 140th of 315 higher than 169 of 315 other Schizophrenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01773278 · 100 participants · Phase 2

    Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00525304, the US trial registry maintained by the National Library of Medicine. NCT00525304 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.